Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period  by Karamlou, Tara et al.
CONGENITAL HEART DISEASEEvolution of treatment options and outcomes for hypoplastic left
heart syndrome over an 18-year periodTara Karamlou, MD,a,b Brian S. Diggs, PhD,a Ross M. Ungerleider, MD, MPH,c and
Karl F. Welke, MD, MScFrom th
Ore,
Arbo
Child
Read at
ation
Receive
publi
Address
Healt
(E-m
0022-52
Copyrig
doi:10.1
C
H
DObjectives:We aimed to describe management strategies for neonates with hypoplastic left heart syndrome over
the past 18 years in the United States and to identify determinants of institutional management decisions.
Methods:Neonates with hypoplastic left heart syndrome were retrospectively identified by use of the Nationwide
Inpatient Sample 1988–2005. Treatment was categorized as (1) transplantation, (2) Norwood operation (as
defined by Risk Adjustment in Congenital Heart Surgery), (3) transfer to another facility, or (4) no surgical
intervention (comfort care).
Results: A total of 3286 neonates were identified, yielding a national estimate of 16,781  586 cases. Of these,
2% (348 47) underwent transplantation, 16% (2767 286) had Norwood operations, 25% (4143 156) were
transferred to another facility, and 57% (9523  436) had comfort care. Changes in practice patterns occurred
over time, with an increasing number of neonates undergoing Norwood, concomitant with decreasing numbers
undergoing transplantation (P< .001). Bias toward the Norwood operation over time paralleled a significant,
nearly linear decrease in the in-hospital mortality rate for the Norwood operation, from 86% in the earliest sextile
to 24% in the most recent sextile (P<.001). Prevalence of transfer to definitive care hospitals remained constant
over time, as did the number of infants (approximately half) who received no surgery (comfort care).
Conclusions: Despite improved surgical outcomes, the majority of infants continue to receive no surgical care.
There has been an increase in the number of infants offered the Norwood operation for hypoplastic left heart
syndrome over the past 2 decades, which seems to have come mostly owing to a decrease of transplants. The
advent of prenatal diagnosis has not decreased the proportion of neonates born at institutions unequipped to
provide definitive care. (J Thorac Cardiovasc Surg 2010;139:119-27)Hypoplastic left heart syndrome (HLHS) remains one of the
most challenging diagnoses in the field of congenital heart
disease. Despite recent innovative techniques in surgical
treatment, including the hybrid strategy (pulmonary arterial
banding with ductal stenting) and ABO-incompatible trans-
plantation, long-term survival remains suboptimal and qual-
ity of life incompletely assessed.1-3 It is unclear what factors
motivate an institutional choice toward surgical treatment
versus no intervention, especially considering the lack of
consensus among physicians, 40% of whom recommended
a disparate treatment strategy than they would themselves
choose.1,4-9 Additionally, given the comparatively poor
long-term prognosis of HLHS, especially among certain
subsets of patients with concomitant syndromes (Turner
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The Journal of Thoracic and Cacare without intervention (comfort care) may be underused
in the United States,10,11 although data elucidating the
incidence of comfort care are lacking.
There have been three major reports1,4,5 chronicling the
national practice patterns for infants with HLHS. However,
none of these included the most recent era with the introduc-
tion of newer management strategies, fetal intervention, and
widespread prenatal diagnosis, which may have major
impact on treatment selection. Additionally, prior reports
have not included the entire spectrum of United States hos-
pitals treating infants with HLHS, nor used a validated and
widely accepted algorithm to define the Norwood opera-
tion.12
We therefore undertook this study to determine current
practice national patterns for HLHS and identify determi-
nants associated with a decision toward a particular manage-
ment strategy. We also focused on national in-hospital
mortality and morbidity trends over the course of an
18-year period.METHODS
Data Set: The Nationwide Inpatient Sample (NIS)
The NIS is the largest all-payer inpatient care database in the United
States. The NIS is managed under the Healthcare Cost and Utilization Pro-
ject of the Agency for Healthcare Research and Quality.13 The database is
a stratified, cross-sectional sample that includes approximately 20% of all
non-federal hospital discharges in the United States. The sampling protocol
is such that when a hospital is chosen, all discharges from that hospital forrdiovascular Surgery c Volume 139, Number 1 119
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D12Abbreviations and Acronyms0CI ¼The Jourconfidence intervalHLHS ¼ hypoplastic left heart syndrome
ICD-9-CM ¼ International Classification of
Diseases, ninth revision, clinical
modificationNIS ¼ Nationwide Inpatient Sample
OHTx ¼ transplantation
RACHS-1 ¼ Risk Adjustment in Congenital
Heart Surgerythe selected time period are included. To ensure the representative nature of
the database, the NIS is stratified by geographic region, urban versus rural
location, teaching status, hospital ownership, and hospital bed size. This
study’s data were derived from the combination of the NIS databases
from 1988 to 2005, and our analysis uses sampling weights provided within
the NIS to derive national estimates. The sampling frame of the NIS has
been nearly constant over time except for a modification in 1998, which
excluded short-term rehabilitation hospitals from the sampling frame. To
account for this small change, we have used the revised NIS trend weights,
published by the Agency for Healthcare Research and Quality,13 which
allows one to compare across years with the same effective sampling
scheme. The NIS is not a self-selecting, and potentially growing, set of hos-
pitals reporting their data. Rather, it is a national sample of hospitals repre-
senting 20% of all discharges. Additionally, it is designed to provide
national estimates, not a total of participating hospitals. NIS data are avail-
able from 1988 to 2005 over which time the number of states participating in
the NIS has grown from 8 to 37. In 2005, the database contained discharge
data on approximately 8 million hospital stays at 1054 hospitals in 37 states.
Patients and Hospitals
We sought to identify the most homogeneous population of infants with
HLHS, whose morphologic features would be amenable to either Norwood
operation or transplantation (OHTx), and therefore excluded those infants
with other complex cardiac anomalies (eg, total anomalous pulmonary
veins, heterotaxy syndrome). The NIS database was searched for the indi-
vidual years 1988 to 2005, selecting out hospital discharges that met the
following criteria: (1) infants 30 days of age or younger; (2) possessed a pri-
mary International Classification of Diseases, ninth revision, clinical mod-
ification (ICD-9-CM) diagnosis code of 746.7 (HLHS) without
concomitant cardiac diagnoses; (3) underwent a surgical procedure (Nor-
wood operation or OHTx), were transferred to another facility, or were dis-
charged from the hospital or died in-hospital without any intervention
(comfort care). Discharges with additional cardiac procedure codes were ex-
cluded. Because there is no ICD-9-CM code for the Norwood operation, we
used the Risk Adjustment in Congenital Heart Surgery (RACHS-1) defini-
tion with slight modification to identify these patients as described in Ap-
pendix 1. The ICD-9-CM procedure code 37.5 was used to identify
patients undergoing OHTx.
To minimize an important source of error, we also determined, to the
extent possible, the final disposition of transferred neonates. The NIS con-
tains admission codes identifying neonates who were received in-transfer
from another hospital. We therefore were able to determine the disposition
of neonates whowere transferred from a hospital included in the NIS sample
that year to a hospital that was also includedwithin the NIS sample that year.
We incorporated this admission code and then reanalyzed our data set to
investigate trends in final treatment for neonates who were transferred
over time. We then compared the disposition of the transferred neonatesnal of Thoracic and Cardiovascular Surgat the receiving hospital to the disposition of neonates who were not
transferred.
Statistical Analysis
Overall descriptive statistics were computed. Treatment groups were
compared by the Rao–Scott c2 for categorical variables or t test for contin-
uous variables. Years were grouped into sextiles and annual RACHS-1
volume for each unique hospital was calculated. The probability for each
management option was investigated by multivariable ordinal regression
models (PROC SURVEYLOGISTIC), adjusted for patient and hospital
level characteristics. Risk-adjusted in-hospital mortality was also compared
among surgical treatment strategies (OHTx or Norwood) with multivariable
ordinal regression using PROC SURVEYLOGISTIC. C-indices were
generated for all logistic regression models to provide insight into model
discrimination. SAS software, version 9.1 (SAS Institute, Inc, Cary, NC)
was used to fit the models to account for the survey design of the NIS,
the potential clustering of outcomes within a hospital, and the decrease in
clustering occurring over increasing time intervals. Institutional review
board approval was obtained, but given the de-identified nature of the
NIS, patient consent was waived for this study.RESULTS
Case Mix
We identified 3286 cases from 586 NIS hospitals during
the study period, yielding a national estimate of 16,781 
586 cases. Of these, 2% (348  47) were OHTx, 16%
(2767  286) were Norwood operations, 25% (4143 
156) were transfers to other facilities, and 57% (9523 
436) involved comfort care. Demographics and clinical
characteristics of the study patients are shown in Table 1.
Age was not included because our inclusion criteria limited
the study population to neonates (30 days of age). Overall,
there was a significant increase in the proportion of neonates
undergoing the Norwood operation over time (weighted fre-
quency 39.9  14.6 [2% of total cases] in the first sextile
[1988–1990] versus 923.8  164.2 [24% of cases] in the
most recent sextile [2003–2005]; P<.001). In contradistinc-
tion, OHTx prevalence declined steadily from a peak of 120
 13 (5% of cases) in the third sextile (1994–1996) to 14 
6 (<1% of cases) in the most recent sextile (P< .001).
Despite the increased national popularity of the Norwood
operation, however, the proportion of neonates having non-
operative therapy, either comfort care or transfer (P ¼ .03),
also rose modestly over time (Figure 1).
Hospital length of stay was longest for patients undergo-
ing OHTx (65  4 days), with Norwood patients having an
average length of stay of 30  1 days. Importantly, those
neonates undergoing no intervention still had an average
length of stay of 11  1 days.Mortality
There were 975 total deaths out of 3286 neonates
(national estimate of 5002  215) during the study
period, yielding an overall mortality rate of 30%. Overall
mortality was higher for the Norwood operation (n ¼
178/975; 18%) than for OHTx (n¼ 21/975; 2%). However,ery c January 2010
TABLE 1. Demographic and clinical characteristics of study patients among treatment types
Variable Norwood OHTx Comfort care Transfer
Female 1047  135 (38%) 151  27 (43%) 3586  186 (38%) 1475  83 (36%)
Race
White 1106  137 (54%) 187  28 (76%) 3578  214 (60%) 1737  80 (65%)
Black 235  47 (11%) 0 (0%) 687  81 (11%) 359  47 (14%)
Hispanic 354  67 (17%) 37  13 (15%) 1342  163 (22%) 391  38 (15%)
Asian/PI 44  14 (2%) 9  4 (4%) 76  16 (1%) 38  11 (1%)
Native Am 28  6 (1%) 0 (0%) 32  14 (1%) 15  9 (1%)
Other 285  59 (14%) 13  5 (5%) 287  47 (5%) 117  23 (4%)
Charges (USD) 249,161  11,066 406,245  25,856 60,422  4,230 10,928  957
LOS (d) 30  1 65  4 11  1 2  0.2
Hospital type
Rural 0 (0%) 0 (0%) 250  9 (2%) 285  11 (7%)
Urban NT 249  80 (9%) 84  30 (24%) 2521  187 (27%) 1303  62 (31%)
Urban T 2518  274 (91%) 264  36 (76%) 6738  394 (71%) 2555  142 (62%)
Annual RACHS-1 volume 246 (17–723) 237 (82–298) 112 (0–723) 0 (0–723)
OHTx, Transplant; PI, Pacific Islander; Am, American; USD, United States dollars; LOS, length of hospital stay; NT, nonteaching; T, teaching.
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DNorwood-specific mortality decreased nearly linearly over
time, from 86% (6/7) in the earliest sextile to 24%
(47/191) in the most recent sextile, whereas in-hospital
mortality for OHTx remained constant (Figure 2).
Multivariable factors increasing the probability of in-
hospital death included earlier year sextile (P<.001) for ear-
liest year sextile compared with most recent sextile, lower
annual RACHS-1 case volume (P¼.002), and female
gender. Norwood operation was not associated with anFIGURE 1. Distribution of case-mix in year sextiles. An increase in the
Norwood operation is seen over time concomitant with a small decrease
in the number of OHTx. Despite increasing application of the Norwood op-
eration, comfort care remains the most common treatment choice. Raw
numbers (estimates) of the total number of neonates with HLHS within
each sextile are as follows: sextile 1: 406 total (national estimate, 2393); sex-
tile 2: 458 total (national estimate, 2469); sextile 3: 437 total (national esti-
mate, 2202); sextile 4: 583 total (national estimate, 2921); sextile 5: 606
total (national estimate, 2935); sextile 6: 796 total (national estimate, 3862).
The Journal of Thoracic and Caincreased risk of death (P¼.40), but OHTx was protective
(P¼.002; Table 2).Evolution of Treatment Patterns for Transferred
Patients
Because an important number of patients within our study
were transferred to another hospital, we investigated the
disposition of these neonates over time. The proportion of
patients transferred in over time has remained relatively
constant over time, from 43% (248/572) in 1988 to 40%
(738/938) in 2005 (Figure 3). Regarding disposition of the
transferred-in patients, we found, as expected, an increase0
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FIGURE 2. Mortality for the Norwood operation and OHTx is displayed
over time, divided into year sextiles. Norwood mortality decreased in
a nearly linear manner over time. Note the widening confidence intervals
for OHTx mortality within all but 1 of the year sextiles, indicating that
increased mortality may be confounded the small number of OHTx cases
in these periods.
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TABLE 2. Multivariable factors associated with in-hospital mortality
Variable Odds ratio 95% CI P value
Treatment type
Comfort care* (reference category)
Norwood 1.13 0.85–1.49 .40
OHTx 0.47 0.29–0.76 .002
Year sextile
1988–1990 6.00 4.14–8.70 <.001
1991–1993 4.31 3.05–6.10 <.001
1994–1996 3.91 2.74–0 5.61 <.001
1997–1999 2.19 1.52–3.17 <.001
2000–2002 1.58 1.09–2.29 <.001
2003–2005* (reference category)
Annual RACHS volume 0.98 0.98–1.0 002
Male 0.83 0.70–0.99 .04
Hospital type
Rural 0.91 0.66–1.27 .58
Urban nonteaching 1.01 0.76–1.35 .93
Urban teaching (reference category)
CI, Confidence interval. *Reference category.
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FIGURE 3. Graphic display of the admission sources for neonates with
HLHS over time. The years are shown on the horizontal axis and the pro-
portion of neonates with each admission code is on the vertical axis. The
legend at the figure right shows the different codes within the NIS. Neonates
who were transferred in bear an admission code ‘‘admitted from another
hospital,’’ shown in dark blue. The number of transferred neonates has de-
creased only slightly during the 18-year period. LTC, Long-term care.
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cal intervention at the receiving hospital over time, from 4%
(11/248) in 1988 to 47% (348/738) in 2005. There was
a corresponding decrease in the proportion of patients hav-
ing comfort care at the receiving hospital, although this
group still comprised nearly 50% of the total (Figure 4).
Determinants of Treatment Selection
Institutions could be broadly classified into those that
predominantly chose surgical treatment, either Norwood
or OHTx (eg, interventional hospitals), and those that pre-
dominantly chose nonoperative management or transferred
patients admitted with a diagnosis of HLHS to other insti-
tutions (eg, noninterventional hospitals) (Figure 5). There
were clear treatment biases, with the majority of hospitals
choosing to transfer neonates with HLHS or provide com-
fort care. A minority of hospitals uniformly provided the
Norwood operation and a small number provided OHTx
as the only interventional option, with the other neonates
admitted to that hospital either receiving comfort care or
being transferred to another facility. Importantly, hospitals
providing both Norwood operation and OHTx have the
highest percentage of intervention in neonates with
HLHS and used transfer with decreasing frequency. Ex-
cepting the patients that are transferred, these data also
demonstrate that the type of care primarily performed at
the initial admitting institution is a primary determinant
in the treatment that a neonate with HLHS receives. Neo-
nates admitted to noninterventional hospitals generally do
not undergo operation whereas neonates admitted to inter-
ventional hospitals generally undergo either Norwood or
OHTx.
There was a significant increase in the percent of neonates
initially admitted to a hospital capable of providing surgical122 The Journal of Thoracic and Cardiovascular Surgintervention over time from 2.5% (95% confidence interval
[CI], 1.1–3.9) in the earliest sextile (1988–1990) to 23.0%
(95% CI, 17.3–28.6) in the fourth sextile (1997–1999)
(P< .001). However, after this initial increase, the preva-
lence of initial admission to an interventional hospital has
remained nearly constant with only 24.3% (95% CI,
17.8–30.8) of neonates in the recent era (2003–2005) admit-
ted to definitive care institutions (Figure 6).
Multivariate modeling uncovered several factors associ-
ated with a patient undergoing operative treatment for
HLHS. Significantly fewer patients underwent the Norwood
procedure or OHTx in the earliest year sextile (1988–1990)
than in the most recent year sextile (2003–2005) (regression
coefficient2.0; P< .001). Patients at rural hospitals were
less likely to undergo operative intervention for HLHS
than those at urban teaching hospitals (regression coefficient,
14.5; P<.001) as were those neonates admitted to hospitals
with lower annual RACHS-1 categorized pediatric surgical
case volume (regression coefficient,0.004; P< .001).
Influence of Hospital Volume on Management
Strategy
The median annual number of RACHS-1 coded cases
performed among included hospitals was 107 (range,
0–723). Higher annual RACHS-1 volume was significantly
associated with a decision toward Norwood operation (odds
ratio, 1.004; 95% CI, 1.004–1.005; P< .001). Figure 5 isery c January 2010
FIGURE 4. Number of neonates having each treatment type over time segregated by whether they were transferred from another hospital (transferred in) or
whether they were admitted directly (not transferred in). The legend at top describes the color-coded 4 treatment types, the years are shown at the horizontal
axis, and the proportion of neonates having each treatment type is on the vertical axis.Regarding the subset of patients who were transferred, there has been an
increase in the number of neonates who underwent subsequent surgical intervention at the receiving hospital over time, from 4% (11/248) in 1988 to 47%
(348/738) in 2005. There was a corresponding decrease in the proportion of patients having comfort care at the receiving hospital, although this group still
comprised nearly 50% of the total in 2005.
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Da graphic description of the proportion of neonates managed
with a particular treatment strategy within each hospital as
a function of increasing percent intervention, excluding
those hospitals whose annual RACHS-1 volume was less
than 3 cases, and segregating OHTx and non-OHTx hospi-
tals. There are clear treatment biases, with the majority of
hospitals choosing to transfer neonates with HLHS or
provide comfort care. A minority of hospitals uniformly
performed the Norwood operation as the only surgical ther-
apy and a small number provide only OHTx. Importantly,
hospitals providing both the Norwood operation and
OHTx had the highest percentage of intervention in neonates
with HLHS and used transfer with decreasing frequency.FIGURE 5. Graphic description of the proportion of neonates managed
with a particular treatment strategy within each hospital (vertical axis), as
a function of increasing percent intervention, excluding those hospitals
whose annual HLHS volume was less than 3 cases. The different colored
shaded areas are confluent histograms from each institution and represent
the 4 possible treatment options. There are clear treatment biases, with the
majority of hospitals choosing to transfer neonates with HLHS or provide
comfort care (blue and red shaded areas at left). A minority of hospitals
uniformly choose Norwood operation (green areas), and a small number
provide only OHTx (pink areas). Importantly, hospitals providing both
the Norwood operation and OHTx have the highest percentage of interven-
tion (and are therefore located at the far right on the plot) in neonates with
HLHS and used transfer with decreasing frequency.DISCUSSION
We have documented the national changes in manage-
ment strategy for HLHS over an 18-year period. National
use of the Norwood procedure has increased commensurate
with declining in-hospital mortality. A portion of this
increase in use has come at the expense of OHTx, which
has declined substantially. Despite the increased popularity
of the Norwood operation in the recent era, the majority of
neonates with HLHS still receive no intervention or require
transfer to a defintive care hospital. Importantly, we found
that institutional biases exist, whereupon infants with
HLHS seem to receive the type of care primarily offered at
the admitting institution, whether this be surgical interven-
tion or comfort care.
Three earlier reports by Gutsegell and Massaro,5 Gutse-
gell and Gibson,4 and Chang, Chen, and Klitzner1 haveThe Journal of Thoracic and Caelucidated similar trends albeit in an earlier time period
before the widespread use of prenatal diagnosis and fetal in-
tervention. These earlier reports, though, showed a morerdiovascular Surgery c Volume 139, Number 1 123
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FIGURE 6. Percent of neonates with HLHS admitted to either an interven-
tional or noninterventional hospital (vertical axis) segregated by year sex-
tiles. An interventional hospital was defined as a hospital that provided
either Norwood operation or OHTx at least once during an annual period.
A significant increase in the proportion of neonates admitted to interven-
tional hospitals is noted up to 1999, after which point there is no significant
increase.
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one study,4 coupled with a lower prevalence of nonoperative
management. On the basis of their data, Chang, Chen, and
Klitzner1 predicted that the Norwood operation would be
undertaken in 50% of neonates by 2004. Our study, in con-
tradistinction, suggests that although the Norwood operation
has increased nationwide, it is still performed in the minority
(25%) of infants in the recent sextile). Moreover, we found
that the average percentage of neonates undergoing no inter-
vention over the entire 18-year period was higher than that
reported by Chang, Chen, and Klitzner1 at nearly 58%
and declined only slightly over time. Discrepant findings
may be due in part to differences in the sampling population.
We used the NIS, which may be more representative of the
overall treatment patterns within all US hospitals (including
community and nonteaching institutions) as opposed to
a consortium of university hospitals as was used in the stud-
ies by Gutsegell and Gibson4 and Gutsegell and Massaro,5
which may have biased their data toward more aggressive
treatment protocols.
We also found that an important number of neonates
were transferred to other hospitals after initial admission,
presumably because they required a higher level of care
than available at the admitting institution. The proportion
on neonates transferred after initial admission to rural or
urban nonteaching hospitals (38%) underscores this con-
tention. The cost of care for these infants, over 10,000
USD, was not inconsequential, and it is likely that definitive
care was delayed in these infants. Infants with certain mor-
phologic features requiring urgent intervention, including124 The Journal of Thoracic and Cardiovascular Surgan intact or highly restrictive atrial septum, are particularly
fragile and thereby prenatal triage to a facility equipped to
provide definitive care would be advantageous to improve
outcome.14-16 Studies by Vlahos,14 Rychik,17 and their col-
leagues have reported nearly 50% 30-day mortality for this
subset compared with 9% for age-matched control patients
with HLHS. We attempted to identify infants within this
category by selecting those in whom a preoperative balloon
atrial septostomy was performed, but the number (n ¼ 10)
identified was insufficient to determine whether an impor-
tant proportion required transfer or received comfort care.
However, this limitation notwithstanding, our study high-
lights an enduring shortcoming of care for infants with
HLHS. Our data suggest that even with widespread avail-
ability of prenatal diagnosis, an important number of neo-
nates, especially in the rural setting, are still admitted to
hospitals not able to provide definitive care. Elucidation
of antenatal surveillance and treatment paradigms focused
on families residing in rural areas may lead to an overall
survival benefit.
Over the 18-year study period, use of the Norwood oper-
ation increased nearly linearly concomitant with steadily
decreasing national rates of OHTx from a peak in 1996 of
nearly 5% of total HLHS cases to less than 1% of total cases
in 2005. Although we cannot determine the precise causes of
this decline from our retrospective analysis, we agree with
Chrisant and colleagues8 that decreasing national OHTx
rates reflect a trend toward Norwood palliation. The bias
toward the Norwood operation is compounded by improved
short-term outcomes coupled with the fact that infants with
HLHS have particularly high pretransplant attrition, with
nearly 25% dying before receiving an organ despite rela-
tively short wait-list times of less than 18 months.6
A traditional perception has been that the United States is
considerably more aggressive in treating infants with HLHS
surgically than other developed countries,10 a dichotomy
articulated by Elliott as ‘‘life at any cost’’ in the United
States compared with a European approach of ‘‘quality is
more important than quantity.’’ It is unlikely that incidence
rates of HLHS have important global variation, but it cer-
tainly is true that termination rates in the United States are
lower (near 17%), thus increasing the potential number of
neonates born with HLHS.18 Brackley and colleagues19
reported a 44% termination rate in an active center in the
treatment of HLHS in Birmingham, and another unit in
London reported a 63% elective rate of termination in pre-
natally diagnosed HLHS.20 Surprisingly, though, despite
the emerging popularity of the Norwood operation in US
hospitals, we also found that ‘‘no treatment’’ (comfort
care) still represents the most common treatment option for
infants with HLHS nationwide. Furthermore, our study
found that comfort care was used in over 50% of neonates
in the most recent sextile, suggesting that physicians may
be adopting a more balanced approach to infants with HLHS.ery c January 2010
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complex, involving the desires and belief systems of both
physician and parents. Vandvik and Forde21 reviewed the
characteristics of 20 mothers of neonates with HLHS, 10
of whom had children who survived surgery and 10 of
whom had children who died after the mothers opted for
comfort care. Mothers choosing comfort care (a choice
motivated by a desire to ‘‘prevent suffering’’) were more
educated, more likely to be employed in health care, and
reported a better childhood environment than those mothers
choosing surgery (a choice perceived as the only acceptable
option). Physician influences were examined in a recent pro-
vocative article by Kon, Ackerson, and Lo.7 These authors
examined how 454 physicians in the United States made
treatment recommendations to parents of infants with
HLHS and what factors motivated these recommendations.
These investigators found that 26% of physicians did not
discuss comfort care, and 25% of those at nontransplant
centers do not discuss OHTx with parents, indicating that
physicians recommend the treatment preferred at their own
institution even when they predict better outcomes with
another approach.7
LIMITATIONS
Using an administrative discharge database such as the
NIS predisposes our study to coding errors and limits our
outcomes to investigation of in-hospital mortality. We
have tried to limit the influence of coding errors by requiring
that study patients both possessed a diagnosis code for
HLHS and fulfilled the RACHS algorithm for a Norwood
operation. Furthermore, although we have included an anal-
ysis of the final disposition of patients who were transferred
to other facilities, the lack of patient identifiers precludes us
from knowing the final disposition (ie, Norwood, OHTx,
death) of all patients transferred from the initial hospital
and introduces the possibility that we have counted some
patients twice.
CONCLUSION
Clinical management of neonates with HLHS has evolved
over time, with an increased proportion of neonates
undergoing the Norwood operation. However, there are
strong institutional biases toward a particular management
strategy, and nonoperative treatment is still used in the
majority of US hospitals. Hospitals performing a higher
number of RACHS cases most likely treat neonates surgi-
cally, and those hospitals providing both OHTx and the
Norwood operation intervene in the highest proportion of
neonates. Despite the more widespread application of prena-The Journal of Thoracic and Catal diagnosis, a substantial number of neonates are initially
admitted to hospitals not equipped to provide definitive care.References
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APPENDIX 1. RACHS-1 DEFINITIONS AND
ALGORITHM USED TO IDENTIFY NORWOOD
Operation
Require:
Dx 746.7 Hypoplastic left heart syndrome
Proc 35.41 Enlargement of existing atrial septal defect
or 35.42 Creation of septal defect in heart
Proc 39.0 Systemic–pulmonary artery shunt
or 35.92 Creation of conduit between right ventricle and
pulmonary artery
Proc 38.35 or 38.45 Resection of thoracic vessel
or 38.34 or 38.44 Resection of abdominal aorta
or 38.64 or 38.65 Other excision of vessel/aorta
or 38.84 or 38.85 Other surgical occlusion of vessel/
aorta
or 39.56, 39.57, 39.58 Repair of blood vessel
or 39.59 or 36.99 Other operation on vessel of heart
Cannot have:
Proc 35.94 Creation of conduit between atrium and
pulmonary artery
Proc 35.95 Revision corrective procedure on heart
Proc 39.21 Cavo–pulmonary artery anastomosis
Allow:
Dx 745.5 Ostium secundum atrial septal defect
Dx 746.3 Congenital stenosis of aortic valve
Dx 746.5 Congenital mitral stenosis
Dx 747.0 Patent ductus arteriosus
Dx 747.10 Coarctation of aorta
Dx 747.22 Atresia and stenosis of aorta
Dx 747.89 Other anomalies of great veins
Proc 37.33 Excision of other lesion/tissue of heart
Cannot have:
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Dr David Clarke (Denver, Colo). The data examined from the
NIS include presumably administrative data from about 20% of
hospitals stratified by location, size, teaching, and so forth. Even
if we assume the sample is representative of the entire country,
intrinsic errors known to exist in administrative data, especially
in the specialty of surgery for congenital heart disease, multiplied
by five does not instill confidence in findings even of this well-
done analysis.
Can you confirm that the source of the information is indeed ad-
ministrative hospital data and ideally say something to boost my
trust in its veracity?
Dr Karamlou. Yes, this is administrative data and although
miscoding is a potential important confounder, this confounder is
not solely isolated to just administrative data. As you know, other
clinical databases are somewhat confounded by differing percent-
ages of miscoding.We have tried to reduce the influence of miscod-
ing by using both a diagnosis for HLHS as well as an accepted
algorithm for coding the Norwood operation, which does not
have a distinct procedure code in administrative data.126 The Journal of Thoracic and Cardiovascular SurgSecond, I think if you look outside of the cardiac surgery and
thoracic surgery literature. the NIS is actually very widely used
in other surgical specialties.
Third, this is an administrative database and thus is based on
billing and things like the final disposition of these neonates and
patients. These are among the factors that are likely to be coded
with greater accuracy than a diagnosis, for instance. However,
your point is well taken.
Dr Clarke. Second, although it is not really clear in your man-
uscript, I learned by talking with you yesterday that your cases were
selected on the basis of criteria including an age of less than or
equal to 30 days at the time of admission. Is it possible that patients
could be admitted more than once and therefore be double counted
in your sampling?
Dr Karamlou. Double counting—you have obviously read the
paper—is another of the potential limitations of this study. One of
the things that it is possible to do in the NIS, and which we hope to
do, is to code patients. You can figure out which infants were trans-
ferred in as their initial diagnosis and so potentially there are two
ways to at least reduce this possible confounding. One is to look
at transfers and admitting diagnosis. The second is to calculate
on a mean prevalence of the incidence of surgical intervention
and apply that constant to the neonates, the 20% that were trans-
ferred; then those patients would fall into the bucket of surgical
intervention, and it may reduce some of that confounding. As
yet, we have not done either of those two things.
Dr Clarke. Third, the overall mortality in this study is reported
as 30%. Although some of the survivors had surgical therapy,
a large group was either transferred to another facility or
discharged alive. We therefore do not really know what happened
to many of these babies. It is likely that most of the transfers
received some form of therapy, and it is very plausible to me
over the years that an increasing number of those who were dis-
charged probably were eventually treated. Do you believe this
study actually represents the evolution of the global management
of HLHS or are we really here just peeking at this horse race
through a keyhole?
DrKaramlou. I think it certainly does represent the evolution of
treatment strategies. What we are stating is that this is the treatment
that is initially provided when a neonate is admitted to a particular
institution. I think the findings of this paper are very important if
you look at certain morphologic subsets of infants with HLHS,
those patients who have an intact atrial septum, for example.
Even if they receive subsequent surgical therapy, it may come at
a great cost to those neonates who probably need to be triaged to
an institution that can provide surgical therapy right then.
The other important thing that you mentioned is that we do not
know the final disposition of the neonates who were transferred.
However, using one of the two methods that I just spoke to you
about, I think it is possible to at least learn a bit more about the per-
centage that were transferred.
Dr David Ross (Edmonton, Alberta, Canada). I am astounded
that you showed such a high rate of nonintervention. In Edmonton,
since 2004, our first-stage mortality is 6% for HLHS, and I know
there are many other centers achieving these results. Yet, when
you talk to neonatologists, it is the only condition for which non-
treatment is offered. There are neonatal and infant cancers that
have far worse survival with far more toxic treatment. If you offerery c January 2010
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Dnontreatment for them, you are told, no, that would be immoral. But
nontreatment is offered to half of the neonates with HLHS. Even
Streptococcal infection in the neonate has a far worse survival,
far worse neurologic survival, and yet no one would ever dream
of not treating it. That is my comment.
My question is this: Do you have any idea why this is continuing
and why these children are singled out for discrimination? Second,
do you have any ideas how to fix this?
Dr Karamlou. I guess I take a little bit of issue with what you
said. I am not making a value judgment that every infant with
HLHS should have surgical therapy. This is actually a dichotomy
that was articulated very well by Martin Elliott in an editorial that
he wrote. That is, in the United States we seem to really favor sur-
gical intervention and it is sort of ‘‘life at any cost,’’ regardless of
the quality of life of those children. This is in contradiction to in the
United Kingdom, for example, or Europe, where nonoperative ther-
apy is selected by a higher proportion of well-educated persons and
even physicians with infants with HLHS. Having said that, I think
one of the primary determinants of nonoperative therapy is that the
infant goes to an institution that does not provide surgical manage-
ment. I think that is one of the important findings in this study.
Dr Thomas Spray (Philadelphia, Pa). Despite the fact that we
may not want to believe your results, I think they are probably
valid. If you go to a national meeting with a group of pediatric car-
diologists and you ask themwhether they offer nonintervention, the
majority say yes. In fact, if you ask them what they would do with
their own child, the majority would say nonintervention. So your
study may actually reflect the true situation.
I would like to make a comment again about these administrative
data sets. If you believe that only 20% of the data is represented,
you would believe that there were 45,000 or more children with
HLHS born in the time frame of the study, which is probably
a vast overestimate of the number in the United States, at least.
That probably is not correct. If you look at an individual institution
and you look at the coding, when we tried to do that in our institu-
tion there was at least a 30% discrepancy in terms of coding accu-
racy, and this is not validated data. That is one of the real problems
with your study, and we are seeing more and more studies using
these national data sets. I would only suggest that maybe something
worth considering is a control population. Take a group in which
you would assume that there is pretty consistent intervention, say
transposition, and in the same data set look at what happens
when you look at transposition rather than HLHS. Do they get
transferred? Do they get operated on? Are they offered noninter-
vention? If you see that there is a relatively high incidence of non-
intervention, then it would lead me to believe that these data sets areThe Journal of Thoracic and Canot really accurate. Then there is the whole problem, as was already
brought up by Dr Clarke, that you do not track what happens to the
individual patient; if the patient is transferred, that patient may get
nonintervention or the patient may get intervention. For the patients
who are classified as nonintervention in your group, you do not
know whether every one of those patients died while they were
in the hospital (which theoretically they should have if they were
given comfort care and nonintervention). It is important to track
what happens to these patients or really you are just getting a snap-
shot. Now this is the best data set there is, and I concede that, but I
just would suggest that you might want to try to use control popu-
lations to see whether you can sort out whether this is really accu-
rate.
Dr Karamlou. I think that is an excellent idea, Dr Spray. I think
I would just mention that even though we do not know the final dis-
position of the transferred neonates, that is still only 20% of our
sample. Good idea.
Dr Lawrence Cohn (Boston, Mass). I have one question. This is
outstanding that in the United States of America 57% of patients
with a potentially treatable disease are not treated. I want to ask
a question concerning the coding. Is this premortem or postmor-
tem? Is this, in part, due to a big diagnostic problem? In other
words, are all of these patients diagnosed with this syndrome as
they come in and then given comfort care, or is this a postmortem
diagnosis, with the patients being signed out on the administrative
log and we say that they were given comfort care because the diag-
nosis was unknown?
Dr Karamlou. If that is true, then a large proportion of infants
had the Norwood operation or transplant not for HLHS, which I
find difficult to believe. Most of these diagnoses are administra-
tively coded. I would assume that the majority of them are done
preoperatively or before intervention, but there is no way to be
sure whether or not necropsy findings were used in a proportion
of them.
Dr Cohn. I just meant in the comfort care group where nothing
was done, were these premortem or postmortem diagnoses?
Dr Karamlou.No, because a lot of the infants who had comfort
care actually did not die in the hospital. In a large percentage of
cases, the parents chose to take the neonates home so that they
could die at home, so it would be a premortem diagnosis.
Dr William Brenner (Los Angeles, Calif). In 1977, the late
great Helen Taussig shocked an audience at the Los Angeles Heart
Association when somebody asked her about the future of congen-
ital heart disease. She responded amniocentesis and abortion. That
is not what the audience was expecting.
Dr Karamlou. I am not advocating that either, by the way.rdiovascular Surgery c Volume 139, Number 1 127
